Starting treatment

Step 1 of the All-Wales Adult Asthma Management and Prescribing Guideline provides an overview of inhaled therapies that are applicable to patients with a new diagnosis of asthma, and those patients with mild, intermittent asthma. Contrary to former Asthma Management Guidelines, short-acting Beta-agonists (monotherapy) is not an effective treatment option for this patient group, or any patients with asthma.

Instead, initiate therapy with regular low dose inhaled corticosteroids with short acting beta-agonist PRN.

In this Tutorial, Dr Katie Pink explores this Step further.

Mark as Understood

Resources

All Wales Adult Asthma Management and Prescribing Guideline

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk